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ABSTRACT
The use of microarray technology provides access to the simultaneous expression
of thousands of genes and is revolutionizing the scientific community of functional
genomics. This thesis investigates a cDNA microarray experiment with the goal of
discovering differentially expressed genes across several factors. The analysis first
”normalizes” the data through the VSN package which is a robust calibration and
variance stabilization software that removes systematic bias which could impair the
analysis. A generalized estimating equation (GEE) approach is used to model the
data and investigate the null hypothesis of no difference in expression levels. To
accommodate the numerous hypothesis being tested, we used the q-value method
to control the false discovery rate of the analysis. The analytical procedures are
performed by using the statistical software packages SAS r© and R.
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1 INTRODUCTION
The use of microarray technology provides access to the simultaneous expression
of thousands of genes and is revolutionizing the scientific community of functional
genomics. This technology generates high-dimensional complex data that represents
the concurrent behavior of thousands of genes across various treatments, time points
and/or applications [1]. The introduction of computationally intensive data anal-
ysis methods has helped researchers deal with the huge amount of data produced
by these experiments. Two common approaches of analyzing gene expression array
data are the grouping of similarly expressed genes (i.e. cluster analysis), and the
identification of statistically significant genes whose expression are changing under
varying conditions. For the latter, the biological question of differential expression
can be restated as a problem in multiple hypothesis testing; that is, the simultaneous
test for each gene under the null hypothesis of no association between the expression
levels and the responses or covariates [2].
Herein, a cDNA microarray experiment is analyzed with the goal of discover-
ing differentially expressed genes across several factors. Inherent in the experiment
are statistical challenges that will be addressed in this thesis. The experimental
design, along with the issues and goals of the analysis, are introduced in Chapter
2. Also included in this Chapter is an important process called normalization that
removes systematic bias that could impair the analysis. In Chapter 3, a generalized
estimating equation (GEE) approach is used to model the data and investigate the
null hypothesis of no difference in expression levels across the factors. To control
the false discovery rate of the analysis, the q-value method is discussed in Chapter
4 with the results and conclusions in Chapter 5.
2 BACKGROUND
2.1 cDNA Microarray
The first step in the production of a microarray is the selection of the probes to
be placed on the glass slide. Once the probes have been selected, they are amplified
by a technique known as polymerase chain reaction (PCR) [3], and are placed on
the cDNA microarray in approximately equal amounts by a high-speed robot. Each
spot on the microarray corresponds to a gene or an EST (expressed sequence tag).
The investigators then extract total RNA or mRNA produced from the bio-
logical sample. This may involve various cell types; for example healthy and tumor
cells or treatment and control cells. By using reverse transcription, the mRNA from
the two samples is fluorescently labelled with Cy3 (green) and Cy5 (red), and the
target mixture is hybridized to the probes on the glass slides. The segments of the
mRNA in the target and their complimentary portion among the samples of cDNA
on the glass slide will bind together if finding each other during hybridization. When
completed, the glass slide is washed and a luminous emission is measured by a scan-
ning microscope. Fluorescent intensity for the red and green dye of each spot is
measured separately, and provides a measure of the relative mRNA abundance for
each gene expression in the two cells. The intensity of the green spot measures the
relative mRNA abundance labelled with Cy3, while the intensity of the red spot
measures the relative mRNA abundance labelled with Cy5. Gray spots represent
genes that were expressed in neither cell type.
These measurements provide information about the relative level of expres-
sion of each gene in the two cells. The monochrome images can be colored to provide
a quantitative measure of the relative expression of each gene in the two cells.
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The two major types of microarrays are the spotted cDNA microarrays [4]
and oligonucleotide arrays [5]. The genomic material used to make the array, the
manner in which this material is actually placed on the array, and the design of the
experiments are the defining differences between these two methodologies. Typically,
oligonucleotide arrays are based on the total genome sequence of a particular organ-
ism, and uses strings of oligonucleotide as the probes. Another interesting factor of
the oligonucleotide array is that every probe, referred to as PM (perfect match), is
paired with a single homomeric base change (A ↔ T,G ↔ C) probe referred to as
MM (mismatch) [1]. This mismatch probe is designed to be a hybridization control
for the PM probe. The assessment of every gene in an organism under certain sce-
narios, when compared to a control, provides a subset of genes that are responding
to a stimulus, and thus reacting in the genome.
2.2 Experiment and Data
The experiment is designed to find differentially expressed genes between UV
treatment and control in two inbred lines that are the foundation for many mapping
studies in maize (Dr. Stapleton, personal communication). The design emphasizes
the detection of UV specific effects and interactions between UV exposure and line.
In the experiment, individual seeds were placed one per 6 cm pot, at a density of 36
pots per flat, and grown in the greenhouse without supplementary lighting for ten
days to the two-leaf stage. The two lines were then exposed to 4 hours of ultravio-
let radiation from UV313 bulbs suspended about 30 cm above the plants. Control
plants were placed under UV313 bulbs covered with polyester, which transmits visi-
ble light but excludes UV-B. After UV irradiation, the UV bulbs were turned off and
the plants were allowed to recover for 4 hours in the greenhouse. The second and
3
third seedling leaf from each of four plants were harvested and dropped immediately
into liquid nitrogen. Total RNA was extracted from frozen tissue, and the cDNA
samples were labeled using Cy5 or Cy3, with excess nucleotide and primers removed
via PCR purification kit.
The experiment involved eight maize cDNA Unigene slides, four slides for
the B73 line and four slides for the Mo17 line. Within these cDNA microarrays,
the genetic material is printed three times next to each other; consequently, average
signal intensities and ratio between co-hybridized samples could be assessed multi-
ple times within each microarray and within experiments. The four arrays within
each line set contained duplicate dye swaps for the UV-B treatment and control. In
these dye swapping experiments, the RNA samples from different experiments were
labelled reciprocally.
The data from this experiment was graciously obtained from Dr. James
Blum in a SAS data set with eight columns and a total of 270,512 observations. The
columns in this data set are as follows:
Column 1 – id, the biological description of each gene
Column 2 – name, the gene names as referenced in the experiment
Column 3 – spot, the location of the spot on the array
Column 4 – intensity, expression levels for the corresponding gene
Column 5 – array, the array to which the spot belongs. Levels: 1,2,3,4.
Column 6 – dye, color of dye used for the corresponding gene. Levels: green,
red.
Column 7 – line, line information. Levels: B, M.
Column 8 – trt, treatment information. Levels: treatment, control.
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2.3 Normalization
Due to the many sources of variation inherent in a microarray experiment, it is
important that we remove any systematic variation detected. Even in the replicate
arrays variations are commonly observed. The purpose of normalization is to adjust
for effects which arise from variation in the microarray technology rather than from
biological differences. These variations may arise due to imbalances between red
and green dyes caused by labelling efficiencies or scanning properties. Other sources
of variation include the location of the spot which may include some spatial vari-
ation, or variation due to print-tip; and other differences in print quality, ambient
conditions or simply the scanner settings. Therefore normalization between as well
as within arrays will need to be considered.
We utilized the VSN software developed by Huber [9], in the bioconductor
project (www.bioconductor.org) to normalize the data. The VSN software is a ro-
bust calibration and variance stabilization tool, that removes the dependency of the
variance on the mean. The VSN package provides a calibration procedure and trans-
formation of the expression levels in one model with parameters estimated from the
data. The calibration procedure uses an affine-linear mapping to bring the various
samples onto the same scale, and then performs an arcsinh transformation on the
data. The normalized data should have mean expression levels that are independent
of the variance and on a consistent scale.
Figures 1-4 give histograms of the gene expression level distributions before
and after normalization. The top rows of each figure depict distributions of the four
controls used on the arrays, while the bottom rows depict distributions of the four
UV-B treatments used on arrays. We can see that before normalization the distri-
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Figure 1: Histograms for all B73 arrays before normalization
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Figure 2: Histograms for all Mo17 arrays before normalization
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Figure 3: Histograms for all B73 after normalization
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Figure 4: Histograms for all Mo17 after normalization
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Figure 5: Before the variance stabilization and calibration procedure.
8
Figure 6: After the variance stabilization and calibration procedure.
9
Figure 7: Variance stabilization.
10
butions of both lines have a fair amount of skewness, while after the procedure the
lines exhibit a more stable distribution that is more symmetric in nature.
Figure 5 illustrates the raw expression levels when we compare duplicate ar-
rays. For example, the first graph depicts the relationship between the control on
array 1 and the control on array 2. These two arrays are duplicates in the sense that
they are subjected to identical experimental conditions and the treatment/control
groups are labeled the same.
Figure 6 illustrates the same arrays after normalization via the VSN pack-
age. Generally, all plots have similar shape and range, which indicates the systematic
array- or dye-biases appear to have been removed. By looking at the plots, it appears
that the normalization procedure performed better on the B73 line. The majority
of data points from these 4 B73 plots are well clustered about a diagonal line, while
those from Mo17 line, although improved, still have a considerable amount of noise.
This is most likely caused from the extreme skewness in the Mo17 line. Both lines
exhibit skewness; however, it is much more prominent in the Mo17 line. This prop-
erty proved to be relatively difficult to deal with by this or similar normalization
methods, and needs further investigation.
As shown in Figure 7, we can see that after transformation the variance is
stabilized successfully. The big black dots, connected by lines, show the running
median of the standard deviation. The curve given by the connected line is an es-
timate of the systematic dependence of the standard deviation on the mean. We
can see after variance stabilization, it is an approximately horizontal line without
much overall trend, which indicates that the variance is approximately independent
of the mean intensity. The overall procedure appears to have worked well; however,
11
we notice that at the lower end of the rank of the mean, standard deviations are
unusually spread out. Of course ideally we want the majority of the standard devi-
ation clustered at lower values.
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3 GENERALIZED ESTIMATING EQUATION
3.1 Theory and Motivation
The assumption of normality for data produced in a microarray experiment is
not necessarily a valid one. Also the cDNA microarray under investigation consists
of three replicated spots for each gene sequence, which induces a correlation among
these spots. This correlation must be taken into account for proper inference and
valid hypothesis testing, which is why a GEE model with quasi-likelihood estimators
was chosen for this analysis.
GEE, Generalized Estimating Equations, was first proposed by Liang and
Zeger [6] as a modelling strategy for correlated and clustered data. It is an ex-
tension of Generalized Least Squares approach [7] to non-Normal distributions by
introducing quasi-likelihood methods that can manage correlation structure found
in panel data and longitudinal or repeated measures analysis.
3.1.1 Generalized Linear Model
A generalized linear model has 3 components: the linear predictor, the link
function, and the distribution of the response variable [8]. The Linear Predictor,
which we will denote by η, is η = Xβ, where the parameters β enter in a linear
fashion. The link function is a function of the mean that links the distribution of
the response to the linear predictor. If we denote the mean of y as E(y) = µ, then the
link function can be represented as g(µ), where g(µ) = Xβ, or µ = g−1(Xβ). The
third component of a generalized linear model is the distribution of the response
variable, which is assumed to belong to the exponential family of distributions.
Members of the exponential family of distributions can be written as:
f(y) = exp{yθ − c(θ)
a(φ)
+ h(y, φ)} (1)
where θ is known as the canonical parameter and is a function of µ, and φ is known
as a ”dispersion” or ”scale” parameter.
For example, in the Normal distribution,
f(y) =
1√
2πσ2
exp(−(y − µ)
2
2σ2
)
= exp[−y
2 − 2yµ + µ2
2σ2
− 1
2
ln[2πσ2]]
= exp{yµ −
µ2
2
σ2
− [ y
2
2σ2
+
1
2
ln(2πσ2)]}
where
θ = µ
c(θ) =
µ2
2
a(φ) = σ2
h(y, φ) = −1
2
[
y2
σ2
+ ln(2πσ2)]
The estimating equation in a likelihood based model is the first derivative of the
log likelihood, otherwise known as the score function. In case of the exponential
family, the score function can be derived by the use of chain rule where,
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∂l
∂β
=
∂l
∂θ
∂θ
∂µ
∂µ
∂η
∂η
∂β
In the case of the exponential family, this simplifies to:
∂l
∂βk
=
∑
i
1
V (µi)a(φ)
[yi − µi]
∂µi
∂ηi
xik (2)
where i = 1, . . . , n (n is the number of observations) and V (µi) specifies the
relationship between the mean of yi and the variance of yi.
3.1.2 GEE
If one does not want to make an assumption regarding the probability function of
y, but instead make an assumption with respect to association between the mean
and the variance, then quasi-likelihood methods should be employed. In the quasi-
likelihood framework, the estimating equations are similar to the score function in
the exponential family:
∑
i
V −1(yi − µi)
∂µi
∂β
(3)
or, in matrix form D′V −1(y − µ)
where V = V (µi)τ
2 and D′ represents [∂µ
∂β
] or D′ =


∂µ1
∂β1
· · · ∂µN
∂β1
...
. . .
...
∂µ1
∂βN
· · · ∂µN
∂βN


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In the situation where the observations are independent, the matrix V is
diagonal matrix. However, in the case of correlated or ”panel” data, an approach is
needed to incorporate this information. The seminal paper by Liang and Zeger [6]
contributed a workable system for representing these ideas into the matrix V and a
coherent estimation and interpretation strategy.
They derived a ”working correlation” matrix defined by R(α). In this con-
text, we redefine the matrix V as follows:
V = A
1
2 R(α)A
1
2 (4)
where R(α) is a n×n matrix of correlation coefficients, numbers between −1
and +1, and is fully specified by the parameter α, and Ai is a diagonal matrix with
V (µ) on the diagonal.
A =


V (µ1) 0 0 0 0
0 V (µ2) 0 0 0
0 0
. . . 0 0
0 0 0 V (µn−1) 0
0 0 0 0 V (µn)


Examples of some of the correlation matrices are:
Unstructured:


1 α12 · · · α1n
α21 1 · · · α2n
...
...
. . . α3n
αn1 αn2 · · · 1


The unstructured correlation matrix estimates a different correlation value,
16
αij, for each i 6= j and i < j.
Exchangeable:


1 α · · · α
α 1 . . . α
...
...
. . . α
α α · · · 1


The exchangeable correlation matrix assumes each correlation value, αij(i 6=
j), is the same.
Autoregressive (1):


1 α α2 · · · αn−1
α 1 α · · · αn−2
...
...
. . .
...
αn−1 αn−2 · · · α 1


The autoregressive(1) correlation matrix assumes that observations closer to-
gether are more similar than those farther apart.
The ”general estimating equations” are the result of taking this structure
into account within a quasi-likelihood context. Thus, the estimating equations in the
GEE paradigm are defined in equation (3) with the V matrix defined in equation (4).
With these estimating equations, optimization programs, such as Newton-Raphson
are used to estimate the parameters.
3.2 Model
We used the GENMOD procedure in SAS to fit a GEE model on a gene by gene
basis to the normalized data. The experiment was treated as a split plot design
with the ”block” (or array) considered as the ”whole plot”. For this analysis, we as-
17
sumed there was no array × treatment interaction. The validity of this assumption
is an area of further investigation and is not considered in this thesis. The program
code for this model is shown in Appendix 1. The first model includes terms for
line, treatment, dye and line × treatment interaction. The second model removes
the the line × treatment interaction for those genes who did not have a significant
the line × treatment interaction. The p-values for the line × treatment interaction
were recorded after the first model, and the p-values for the line and treatment were
recorded after the second model.
In the GENMOD procedure, the specified covariance structure of the GEE
model is based on eight clusters (panels), or the eight arrays in the experiment. We
assumed the correlation coefficients consistent across observations, therefore chose
the Exchangeable Correlation Matrix as the structure for the correlation matrices.
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4 FALSE DISCOVERY RATE
4.1 Definition
Classical multiple comparison procedures aim at controlling the probability of
committing even a single type-I error within the tested family of hypotheses. The
main problem with such classical procedures, is that they tend to have substantially
less power than uncorrected procedures. In many instances, lack of multiplicity con-
trol is too permissive, but the full protection resulting from controlling the Family-
wise Error Rate (FWER) is too restrictive. Benjamini and Hochberg [10] introduced
the False Discovery Rate (FDR) - the expected ratio of erroneous rejections to the
number of rejected hypotheses, as an appropriate error rate to control. The FDR
is equal to the family wise error rate when the number of true null hypotheses m0
equals the number of all hypotheses being tested (m) [12], so in such a situation
controlling the FDR controls the FWER as well. But the FDR criterion is adaptive,
in the sense that when some of the tested hypotheses are not true (i.e. m0 < m), the
FDR is smaller, and more so when more of the hypotheses are not true. Hence FDR
controlling procedures can be more powerful than FWER controlling procedures at
the same level.
4.2 Q-values
Table 1 [12] describes the possible outcomes in testing m hypotheses. Note that
R is the total number of hypotheses rejected, and V is the number of false positive
results. So FWER, which is the probability of making one or more type I errors
among all the hypotheses, is defined to be Pr (V ≥ 1). As a very strict error
measure, when the number of tests increases, the power in the FWER procedure
decreases [11]. On the other hand, FDR is defined to be the expected proportion of
Table 1: Outcomes when testing m hypotheses
Hypothesis Accept Reject Total
Null true U V m0
Alternative true T S m1
W R m
20
false positive findings among all rejected hypotheses times the probability of making
at least one rejection.
FDR = E[
V
R
|R > 0]Pr(R > 0) (5)
Benjamini and Hochberg [10] provided sequential p-value methods to fix the
error rate beforehand and to estimate the rejection region.
Storey [12] introduced the positive False Discovery Rate (pFDR), defined as:
pFDR = E[
V
R
|R > 0] (6)
The additional term ”positive” refers to the fact this quantity is estimating
an error rate where at least one positive finding has occurred.
In a multiple hypotheses setting, test statistics for each of the m hypotheses
are calculated, T1, T2, · · · , Tm and each null hypothesis will either be regarded as
true, H = 0, or false H = 1. If we define the rejection region for these hypotheses
test as θ, and the probability that a null hypothesis is true with a priori probability
π0, then pFDR can be defined as:
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pFDR =
π0P (T ∈ θ|H = 0)
π0P (T ∈ θ|H = 0) + π1P (T ∈ θ|H = 1)
(7)
where π1 = 1 − π0
An estimate of π0 can be obtained by
π̂0(λ) =
](Pi > λ)
(1 − λ)m (8)
for some λ, where Pi is the p-value for hypothesis i.
The q-value, defined by John Storey [11], is the minimum pFDR at which a
gene can be called differentially expressed, and is defined as:
q − value(t) = inf
t∈θ
Pr(H = 0|T ∈ θ) (9)
This q-value corresponds to the posterior probability that a gene is not def-
erentially expressed given that gene statistic is as extreme as the one observed for
this gene in the data. These q-values may be used by the investigator as criteria
for selecting all features with q-value less or equal to a chosen false discovery rate
threshold value. We utilized John Storey’s Q-value software in R for our analysis.
Storey [11] provides four useful plots through his Q-value software. Through
these plots, an investigator can choose the optimal q-value or p-value for the analy-
sis. The plots produced in the Q-value software are:
1. The estimated π0 versus the tuning parameter λ
2. The q-values versus the p-values
3. The number of significant tests versus each q-value cut-off
4. The number of expected false positives versus the number of significant tests
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5 RESULTS AND CONCLUSION
5.1 Results from Q-values
Storey [12] recommends allowing the Q-value software to estimate the optimal λ
for the analysis. The software estimates the MSE for λ values ranging from 0.00 to
0.95, and chooses the value that minimizes the MSE. The value for λ is then used
to estimate π0, which is the a priori P (H = 0). However, using this approach to
estimate λ for our data gives unreliable results. For example, using the p-values of
the treatment effect and the estimate of λ provided by the software, π0 is estimated
to be 0.39 indicating that the majority of the genes are believed to be significant,
or differentially expressed, which is very unlikely. Also, the second plot in Figure
8 shows that for a p-value of 0.05 the corresponding q-value is approximately the
same, and a p-value of 0.1 yields a q-value less than 0.1. Since p-values measure the
error rate of a individual test while q-values measure the overall error rate, it does
not make sense to have q-values less than or equal to the corresponding p-values.
Therefore, we decided to choose a λ that produces reasonable value of π0 and make
the analysis more appropriate. We calculated an estimate of π0 from the data by
calculating the proportion of p-values ≤ 0.05. By using this estimate of π0, we were
able to calculate more appropriate values of λ that yielded more consistent results.
The estimate of λ for the treatment p-values was estimated to be 0.065, with
π0 = 0.715. The resulting graphs from the Q-value software are shown in Figure 9.
Again we use a p-value cut-off of 0.05, which yields a q-value of about 0.12. Thus,
we expect approximately 1014 significant tests, among which there are about 120
false positives.
The estimate of λ for the line p-values was estimated to be 0.06, with
π0 = 0.762. The graphs for this analysis are shown in Figure 10. With the same
cut-off p-value of 0.05, the corresponding q-value is around 0.155. Thus, we expect
approximately 851 tests to be significant, among which there are about 132 false
positives.
The estimate of λ for the interaction p-values was 0.1, which gave an estimate
of 0.918 for π0. Figure 11 illustrates the q-value results of this analysis. According
to this output, if we select a p-value of 0.05 as our cut-off, the q-value, or pFDR is
around 0.48. We feel that 48% is rather high for a false discovery rate and conclude
there were no significant interactions.
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Figure 8: Q-value plots for treatment using software-picked λ
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Figure 9: Q-value plots for treatment
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Figure 10: Q-value plots for line
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Figure 11: Q-value plots for interaction
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5.2 Results from Multtest
The biological question of differential expression can be viewed from a multiple
hypothesis perspective: the simultaneous test for each gene of the null hypothesis
of no association between the expression levels. We attempt to compare the results
obtained from the GEE approach and Q-value method to those provided through a
packaged multiple comparison procedure developed by Dudoit et al. [13].
The multtest package under the Bioconductor project was developed in R by
Dudoit and Ge [13]. It performs different procedures such as t-test, F -test, paired
t-test, block F -test and Wilcoxon test that produce p-values which can be adjusted
to control the family wise Type I error rate (FWER). Some of the procedures used
to adjust p-values are Bonferroni, Hochberg, Holm, Sidak, Westfall, Minp and MaxP
etc. [13].
Standardized intensities for both Mo17 and B73 lines were analyzed with the
multtest package separately. The results show that all the adjusted p-values for each
gene are calculated to be 1, therefore fail to choose any significant genes. Due to
the inconsistency between this and our previous results, we decided to run the data
through the Significance Analysis of Microarray (SAM) to take another look at a
different multiple testing procedure. A basic SAM analysis was conducted for the
normalized intensities for each line separately, with 500 balanced permutations. The
results from SAM procedure indicates no significant genes in either line. Since both
multtest and SAM only accept single measurement for each gene, we calculated the
average intensities as the response variable for both analysis. Analyzing the lines
separately and only using the average intensity for each gene on an array reduces
the number of observations per gene, which in turn reduces the power for detecting
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differentially expressed genes.
5.3 Conclusion
The rich information provided by microarray experiment gives possibilities to
discover gene expression patterns under various treatments and/or factors. Design
of the experiment always plays an important role in the analysis of the data. Differ-
ent analysis methodologies however, may yield different results. The question as to
which method is best is still an open question.
We chose Generalized Estimating Equations for this correlated (3 replicated
spots) and clustered (8 arrays) data to ensure proper inference for the layout of the
experiment. Among the 5,376 genes, 1,014 genes are found to be significant (with
140 expected false positives) for the treatment effect. We infer that those genes are
possibly related to the UV treatment and remain as potential candidates for future
biological study. We also found 851 out of 5,376 genes significant (with 132 expected
false positives) for the line factor indicting that these genes have possible significant
different expression levels between the two lines, and should be subjected to future
biological study. We conclude no significant genes for the line × treatment interac-
tion due to high false discovery rates. This means that the UV-B treatment affects
the expression levels similarly within each line.
The box plots in Figure 12 illustrate that treatment and control for both
lines have very similar distributions (from left to right, the box plots are: treatment
for Mo17, control for Mo17, treatment for B73, control for B73). GEE method
treats the data as a whole while multtest and SAM analyze Mo17 and B73 lines
separately and use an average intensity among the three replicate spots. The failure
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of both multtest and SAM to pick up any significant genes is an interesting discov-
ery. Because of the significant sample size reduction for both packages (only 1/6 of
the sample size of the GEE analysis), one may argue that a comparison could be
inappropriate. However, considering the rather large difference between the results
(1014 significant genes versus 0), we still feel that although contributed by its larger
sample size, the GEE method appears to have more power in detecting differentially
expressed genes for UV-B treatment versus a control. However it is unclear as to
which method is the optimal for this analysis.
Although the analysis provides reasonable results, a few issues remain unre-
solved. A better normalization procedure, validation of the assumption of no array
× treatment interaction and what method is the optimal method to use have not
been considered in this thesis and are still open areas for future investigation.
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APPENDIX
SAS Program for GEE
MODEL 1
proc genmod data = test;
class dye array line treatment;
model intensity = line dye treatment line*treatment/dist=normal type3;
repeated subject=array/type=exch;
lsmeans line*treatment;
by name;
make ’type3’ out=p_table;
make ’lsmeans’ out=lsmeans;
run;
data p_value;
set p_table;
if source=’line*treatment’ then
p_value=ProbChiSq;
if mod(_N_,4)=0 then output;
keep name p_value;
run;
MODEL 2
proc genmod data = test2; class dye array line treatment;
model intensity = line dye treatment/dist=normal type3;
repeated subject=array/type=exch;
by name;
make ’type3’ out=p_table;
run;
data p_value_line;
set p_table;
if source=’line’ then
p_value=ProbChiSq;
if source=’treatment’ then delete;
if source=’dye’ then delete;
keep name p_value;
run;
data p_value_trt;
set p_table;
if source=’line’ then delete;
if source=’treatment’ then p_value=ProbChiSq;
if source=’dye’ then delete;
keep name p_value;
run;
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